Fluoroquinolones and the Risk of Serious Arrhythmia: A Population-Based Study | Zendy

Francesco Lapi | Zendy; Machelle Wilchesky | Zendy; Abbas Kezouh | Zendy; Jacques I. Benisty | Zendy; Pierre Ernst | Zendy; Samy Suissa | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Fluoroquinolones and the Risk of Serious Arrhythmia: A Population-Based Study

Author(s) -

Francesco Lapi,

Machelle Wilchesky,

Abbas Kezouh,

Jacques I. Benisty,

Pierre Ernst,

Samy Suissa

Publication year - 2012

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cis664

Subject(s) - medicine , gatifloxacin , moxifloxacin , relative risk , rate ratio , confidence interval , cohort , population , cohort study , incidence (geometry) , cardiac arrhythmia , atrial fibrillation , ciprofloxacin , antibiotics , environmental health , microbiology and biotechnology , biology , physics , optics

Fluoroquinolones have been suspected to cause cardiac arrhythmia but data are lacking, particularly for the individual fluoroquinolones. We assessed the risk of serious arrhythmia, defined as ventricular arrhythmia or sudden/unattended death identified in hospital discharge diagnoses, related to fluoroquinolones as a class as well as for each individual molecule.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research